Cipher Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
4.00
17.00
14.00
13.00
8.00
7.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
12.00
-4.00
-3.00
5.00
2.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
26.00
21.00
13.00
17.00
15.00
10.00
Cash Flow from Investing Activities
-109.00
0.00
0.00
0.00
-1.00
-3.00
Cash Flow from Financing Activities
53.00
-7.00
-2.00
-3.00
-10.00
-12.00
Net Cash Inflow / Outflow
-30.00
14.00
10.00
14.00
3.00
-5.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CAD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cipher Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(CAD)
Change(%)
Profit Before Tax
4.04823647780389
-84.6896551002905
88.00
104.78%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
12.2652660527168
43.7099942676179
-31.00
-71.94%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
26.7772691015752
-32.0283318492647
58.00
183.60%
Cash Flow from Investing Activities
-109.657204950705
42.4345600338326
-151.00
-358.41%
Cash Flow from Financing Activities
53.8340103660851
-12.3337641318675
65.00
536.48%
Net Cash Inflow / Outflow
-30.1227152872934
-1.92753594729952
-29.00
-1462.76%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.07678980424834
0
-1.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 24.01% vs 56.85% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
26.78
21.59
24.01%






